CHF 40,000 for a digital marketplace for healthcare replacements, better data for logistics, and therapeutic monoclonal antibody
23.09.2024
Carewell, LogBook, and REMUUN were selected at Venture Kick's second financial and entrepreneurial support stage. Their projects provide a digital marketplace to manage replacements in healthcare; help logistics professionals manage their location profiles at scale; and replicate the body's natural antibody diversification ex vivo, allowing for unparalleled precision, flexibility, and speed in antibody development.
 |
 |
 Carewell: from left to right, Fabian Mösli, Soazig Olivin, Mathieu Dubois, and Josselin Meylan
|
|
 LogBook: CTO Dr. Leonard Goeltl and CEO Bernhard Elkuch
|
|
 REMUUN founder and chairman, Richard Chahwan
|
|
Carewell: providing a next-gen healthcare recruitment platform
There is a healthcare staff shortage problem, with close to 11’000 FTEs missing in hospitals and other institutions. This has terrible consequences both for healthcare institutions and professionals: trouble filling in plannings, overworked teams, even more professionals leaving healthcare… which in the end has an impact on patient quality of care.
Carewell is the digital marketplace to manage replacements in healthcare, by matching healthcare institutions’ needs with short-term healthcare staff in search for flexibility through digital processes and an AI matching algorithm. Carewell is currently a team of four (Soazig Olivin (nurse by profession), Mathieu Dubois, Josselin Meylan & Fabian Mösli), going after the CHF 750M market of replacements in healthcare in Switzerland.
They will use the VentureKick Stage funds to further test their assumptions, mainly on their capacity to find the right people through online advertising, The startup will also set up its technical foundations, as well as fund the development of its MVP to bring the team towards proof-of-concept for later this summer. Finally, they will build the legal framework around their collaboration with partners.
LogBook: Because Logistics deserves better Data
Accurate master data about locations is required for many aspects of logistics, from network planning to warehouse lease management, however, the knowledge today lives in disparate Excel sheets, inaccessible and outdated. It's everybody's problem, but nobody's job.
The co-founders are Lenny & Bernhard. While Lenny is responsible for product and technology, Bernhard is focused on the market-facing activities. LogBook helps customers to manage their location profiles at scale. Powered by Al & machine learning, LogBook also provides public transport node data at scale (seaports, airports, intermodal terminals, etc). Furthermore, they enable customers to maintain their own geo-locations (incl. mapping, and adding metadata such as location capabilities, business hours, etc) and to share that data with relevant stakeholders easily.
The funds will contribute to the founding process, product development, and first marketing activities such as trade fairs and the creation of collateral, allowing us to pick up momentum and attract further pilot customers.
REMUUN: Rapid, Precise, and Cost-Effective Therapeutic Monoclonal Antibody Development
The global monoclonal antibody market is projected to surpass USD 300 billion by 2025. However, current therapeutic antibody development processes are slow, expensive, and have limited therapeutic potential.
REMUUN, a spin-off from the University of Zurich, is composed of a talented team of scientists and advisors, including Prof Dr Richard Chahwan (Founder), Paulina Wyrzykowska, Melis Nefin Yaganoglu, and Romina Fetti.
Their therapeutic agents are custom-designed monoclonal antibodies, developed using their patented MEGA platform. This modular platform replicates the body's natural antibody diversification ex vivo, allowing for unparalleled precision, flexibility, and speed in antibody development.
The Venture Kick funds will help REMUUN consolidate its intellectual properties and contribute to selecting an immunotherapy target that can proceed to clinical trials.
There is a healthcare staff shortage problem, with close to 11’000 FTEs missing in hospitals and other institutions. This has terrible consequences both for healthcare institutions and professionals: trouble filling in plannings, overworked teams, even more professionals leaving healthcare… which in the end has an impact on patient quality of care.
Carewell is the digital marketplace to manage replacements in healthcare, by matching healthcare institutions’ needs with short-term healthcare staff in search for flexibility through digital processes and an AI matching algorithm. Carewell is currently a team of four (Soazig Olivin (nurse by profession), Mathieu Dubois, Josselin Meylan & Fabian Mösli), going after the CHF 750M market of replacements in healthcare in Switzerland.
They will use the VentureKick Stage funds to further test their assumptions, mainly on their capacity to find the right people through online advertising, The startup will also set up its technical foundations, as well as fund the development of its MVP to bring the team towards proof-of-concept for later this summer. Finally, they will build the legal framework around their collaboration with partners.
LogBook: Because Logistics deserves better Data
Accurate master data about locations is required for many aspects of logistics, from network planning to warehouse lease management, however, the knowledge today lives in disparate Excel sheets, inaccessible and outdated. It's everybody's problem, but nobody's job.
The co-founders are Lenny & Bernhard. While Lenny is responsible for product and technology, Bernhard is focused on the market-facing activities. LogBook helps customers to manage their location profiles at scale. Powered by Al & machine learning, LogBook also provides public transport node data at scale (seaports, airports, intermodal terminals, etc). Furthermore, they enable customers to maintain their own geo-locations (incl. mapping, and adding metadata such as location capabilities, business hours, etc) and to share that data with relevant stakeholders easily.
The funds will contribute to the founding process, product development, and first marketing activities such as trade fairs and the creation of collateral, allowing us to pick up momentum and attract further pilot customers.
REMUUN: Rapid, Precise, and Cost-Effective Therapeutic Monoclonal Antibody Development
The global monoclonal antibody market is projected to surpass USD 300 billion by 2025. However, current therapeutic antibody development processes are slow, expensive, and have limited therapeutic potential.
REMUUN, a spin-off from the University of Zurich, is composed of a talented team of scientists and advisors, including Prof Dr Richard Chahwan (Founder), Paulina Wyrzykowska, Melis Nefin Yaganoglu, and Romina Fetti.
Their therapeutic agents are custom-designed monoclonal antibodies, developed using their patented MEGA platform. This modular platform replicates the body's natural antibody diversification ex vivo, allowing for unparalleled precision, flexibility, and speed in antibody development.
The Venture Kick funds will help REMUUN consolidate its intellectual properties and contribute to selecting an immunotherapy target that can proceed to clinical trials.